Ximino - 10631-330-05 - (minocycline hydrochloride)

Alphabetical Index


Drug Information of Ximino

Product NDC: 10631-330
Proprietary Name: Ximino
Non Proprietary Name: minocycline hydrochloride
Active Ingredient(s): 45    mg/1 & nbsp;   minocycline hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Ximino

Product NDC: 10631-330
Labeler Name: Ranbaxy Laboratories Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA201922
Marketing Category: NDA
Start Marketing Date: 20120901

Package Information of Ximino

Package NDC: 10631-330-05
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-05)

NDC Information of Ximino

NDC Code 10631-330-05
Proprietary Name Ximino
Package Description 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-05)
Product NDC 10631-330
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name minocycline hydrochloride
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20120901
Marketing Category Name NDA
Labeler Name Ranbaxy Laboratories Inc.
Substance Name MINOCYCLINE HYDROCHLORIDE
Strength Number 45
Strength Unit mg/1
Pharmaceutical Classes Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient]

Complete Information of Ximino


General Information